EW
DMTK

Evoke Wealth’s DermTech, Inc. Common Stock DMTK Stock Holding History

Evoke Wealth’s Portfolio DMTK Stock Details DMTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-311
Closed -$16K – 1248
2021
Q1 		$16K Hold
311
– – ﹤0.01% 625
2020
Q4 		$10K Hold
311
– – ﹤0.01% 600
2020
Q3 		$4K Buy
+311
New +$3.6K ﹤0.01% 748

Other funds holding DMTK

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ICM
ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Evoke Wealth's DMTK Position: Q2 2021 in Review

Evoke Wealth sold out of DermTech, Inc. Common Stock (DMTK) in Q2 2021, closing a stake of 311 shares — an estimated $16K sold.

Evoke Wealth first reported a position in DMTK in Q3 2020 and held it in 3 quarters. The position peaked at $16K in Q1 2021. 176 funds tracked by Wall St. Rank hold DMTK as of Q2 2021.

  • Evoke Wealth reported no remaining DermTech, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Evoke Wealth sold 311 DermTech, Inc. Common Stock shares in Q2 2021, an estimated $16K.
  • Evoke Wealth first reported a position in DermTech, Inc. Common Stock in Q3 2020 and held it in 3 quarters.
  • Evoke Wealth's DermTech, Inc. Common Stock position peaked at $16K in Q1 2021.
  • 176 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q2 2021.

Based on Evoke Wealth's 13F filing for Q2 2021, filed 5 Aug 2021.